NURS 3100 Exam 1 Practice

A client has skin lesions that have not responded to prescription drugs. He tells the nurse he has heard about some research going on with a new drug and asks why he can't take it. What is the best response by the nurse?

1. I know it is frustrating, but the FDA approval process is in place to ensure that drugs are safe

2. Maybe you could contact the drug company about becoming involved in a clinical trial

3. The FDA has very strict rules about new drugs; it is important to be patient regarding the review/approval process

4. Your skin lesions really aren't bad, but maybe the new drug will be available soon

The correct answer is: I know it is frustrating, but the FDA approval process is in place to ensure that drugs are safe

The best response by the nurse is A. By stating, "I know it is frustrating, but the FDA approval process is in place to ensure that drugs are safe," the nurse is acknowledging the client's concerns while also providing a clear explanation for why the new drug cannot be accessed immediately. The FDA approval process is crucial for ensuring the safety and efficacy of new drugs before they are made available to the public. This response conveys understanding and reassurance to the client, emphasizing the importance of patient safety in healthcare. Options B, C, and D, are not the best responses in this situation. Option B suggests getting involved in a clinical trial without providing information on the FDA approval process. Option C vaguely mentions the strict rules of the FDA without offering a specific reason as to why the drug is not accessible. Option D downplays the severity of the client's condition and offers false hope without addressing the regulatory process of drug approval.